Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.

Gemma AragonèsTeresa AuguetAlba BerlangaEsther Guiu-JuradoSalomé MartinezSandra ArmengolFàtima SabenchRosa RasMercè HernandezCarmen AguilarJosep ColomJoan Josep SirventDaniel Del CastilloCristóbal Richart

Published in: PloS one (2016)

These findings suggest that alpha-ketoglutarate can determine the presence of non-alcoholic fatty liver in morbidly obese patients but it is not valid a biomarker for NASH.

Keyphrases

obese patients
bariatric surgery
gastric bypass
roux en y gastric bypass
weight loss
liver injury
fatty acid
liver fibrosis
type diabetes
metabolic syndrome
adipose tissue
drug induced